We have shown at a mechanistic level how entities involved in insulin signaling, PI3K/AKT signaling, MTOR signaling, neurotrophin signaling, and microglial-mediated immune responses interact and potentially contribute to the manifestation of characteristic features of both AD and T2DM. The gene discussed is AKT1; the disease is Alzheimer disease.